Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 32532945!ä!32532945 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Infez+Med 2020 ; 28 (suppl 1): 96-103 Nephropedia Template TP {{tp|p=32532945|t=2020. Risk of hepatic failure in COVID-19 patients A systematic review and meta-analysis |pdf=|usr=}}{{32532945}} gab.com Text Risk of hepatic failure in COVID-19 patients A systematic review and meta-analysis JO: Infez Med http://www.kidney.de/pget.php?&tw=1&pmid=32532945 #FOAvip Liver injury has been reported to occur during the disease in severe cases. Therefore, this meta-analysis study aims to investigate the incidence of liver injury among published literature from 2019-Jan-01 to 2020-April-03 to provide an outline for further studies on the liver injury of COVID-19. Four databases including Pubmed, Embase, Web of Science, and the Scopus were searched for studies published from 2019-Jan-01 to 2020-April-03. Data analysis and drawing of charts were performed using the Comprehensive Meta-Analysis Software Version 2.2 (Biostat, USA). The search yielded 450 publications, of which 64 potentially eligible studies were identified for full-text review and 21 studies fulfilling the inclusion criteria remained. A total of 4191 COVID-19 patients were included in our meta-analysis. The pooled prevalence of liver injury was 19.5% (95% CI: 14.3-26.1). According to our results, there was significant heterogeneity among the 19 studies (X2 = 738.5; p < 0.001; I2 = 94.34%). Among 288 death cases, the pooled prevalence of liver injury was 22.8% (95% CI: 11.7-39.8). In summary, the COVID-19 disease itself can result in severe and even fatal respiratory diseases and even may lead to ARDS and multiple organ failure. The results of this systematic review highlight the importance of liver injury that may assist clinicians anywhere in the globe in controlling COVID-19-related infection and complications. Moreover, the prevalence of liver injury can be higher in severe cases than in mild cases. Twit Text FOAVip Risk of hepatic failure in COVID-19 patients A systematic review and meta-analysis ????Infez Med http://www.kidney.de/pget.php?&tw=1&pmid=32532945 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32532945 #FOAvip English Wikipedia <ref>{{Cite pmid|32532945}}</ref> Risk of hepatic failure in COVID-19 patients A systematic review and meta-analysis #MMPMID32532945 Samidoust P; Samidoust A; Samadani AA; Khoshdoz S Infez Med 2020[Jun]; 28 (suppl 1): 96-103 PMID32532945show ga Liver injury has been reported to occur during the disease in severe cases. Therefore, this meta-analysis study aims to investigate the incidence of liver injury among published literature from 2019-Jan-01 to 2020-April-03 to provide an outline for further studies on the liver injury of COVID-19. Four databases including Pubmed, Embase, Web of Science, and the Scopus were searched for studies published from 2019-Jan-01 to 2020-April-03. Data analysis and drawing of charts were performed using the Comprehensive Meta-Analysis Software Version 2.2 (Biostat, USA). The search yielded 450 publications, of which 64 potentially eligible studies were identified for full-text review and 21 studies fulfilling the inclusion criteria remained. A total of 4191 COVID-19 patients were included in our meta-analysis. The pooled prevalence of liver injury was 19.5% (95% CI: 14.3-26.1). According to our results, there was significant heterogeneity among the 19 studies (X2 = 738.5; p < 0.001; I2 = 94.34%). Among 288 death cases, the pooled prevalence of liver injury was 22.8% (95% CI: 11.7-39.8). In summary, the COVID-19 disease itself can result in severe and even fatal respiratory diseases and even may lead to ARDS and multiple organ failure. The results of this systematic review highlight the importance of liver injury that may assist clinicians anywhere in the globe in controlling COVID-19-related infection and complications. Moreover, the prevalence of liver injury can be higher in severe cases than in mild cases. |Adult[MESH] |Aged[MESH] |Betacoronavirus/genetics/isolation & purification[MESH] |COVID-19[MESH] |China/epidemiology[MESH] |Coronavirus Infections/*complications/epidemiology[MESH] |Female[MESH] |Hepatitis, Viral, Human/epidemiology/etiology[MESH] |Humans[MESH] |Iran/epidemiology[MESH] |Liver Failure/epidemiology/*etiology[MESH] |Male[MESH] |Middle Aged[MESH] |Multiple Organ Failure/epidemiology/etiology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*complications/epidemiology[MESH] |Prevalence[MESH] |RNA, Viral/blood[MESH] |Real-Time Polymerase Chain Reaction[MESH] |Reverse Transcriptase Polymerase Chain Reaction[MESH] |Risk[MESH] |SARS-CoV-2[MESH]Risk of hepatic failure in COVID-19 patients A systematic review and (epmc).pdf DeepDyve Pubget Overpricing